Literature DB >> 8046464

Na(+)-dependent, fluoxetine-sensitive serotonin uptake by astrocytes tissue-printed from rat cerebral cortex.

V Dave1, H K Kimelberg.   

Abstract

Previous studies have established that rat primary astrocyte cultures prepared from several brain regions of 1-4-d-old rats exhibit high-affinity, Na(+)-dependent and fluoxetine-sensitive serotonin (5-HT) uptake with a Km for 5-HT of 0.4 microM and a Ki for fluoxetine of 23 nM, which correspond to the characteristics for this transport for other brain preparations. However, it is not known whether astrocytes in situ show such uptake. We addressed this question by performing 3H-5-HT uptake experiments on cortical astrocytes, within 4 hr of isolating them from 6- and 21-d-old rats by the tissue-print technique. Quantitative autoradiography was combined with GFAP and neurofilament (NF) immunocytochemistry to distinguish astrocytic from neuronal 3H-5-HT uptake. In composition, the tissue-printed (TP) cells and processes were 60-70% GFAP (+) and 10-15% NF(+). 3H-5-HT uptake (0.3 microM 5-HT, 3.4 microCi/ml) in both tissue-printed GFAP(+) astrocytes and NF(+) structures was sensitive to 1 microM fluoxetine and was also Na+ dependent. More than 90% of TP astrocytes from 6- and 21-d-old rats and 100% of NF(+) structures from 21-d-old rats showed positive 3H-5-HT uptake (defined as > or = 31 grains/10(3) microns2). The highest level of uptake (> or = 191 grains/10(3) microns2) was never observed in TP astrocytes but was exhibited by about half of the NF(+) structures. In other experiments were found that 3H-5-HT uptake by 6-d-old TP astrocytes was comparable to uptake by postnatal age-matched primary cultured astrocytes that were grown in fetal bovine serum (FBS). However, primary cultured astrocytes grown in horse serum showed lower uptake than that observed with FBS, a finding similar to previous results in cultures where 3H-5-HT uptake was measured per milligram of cell protein. These results imply that high-affinity, Na(+)-dependent and fluoxetine-sensitive 5-HT uptake occurs in rat cortical astrocytes in situ.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8046464      PMCID: PMC6577174     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  11 in total

Review 1.  The role of neurotransporters in excitotoxicity, neuronal cell death, and other neurodegenerative processes.

Authors:  K P Lesch; A Heils; P Riederer
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

2.  Mucosal mast cell secretion processes imaged using three-photon microscopy of 5-hydroxytryptamine autofluorescence.

Authors:  R M Williams; J B Shear; W R Zipfel; S Maiti; W W Webb
Journal:  Biophys J       Date:  1999-04       Impact factor: 4.033

3.  Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density.

Authors:  G Huether; D Zhou; E Rüther
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Ultrastructural localization of the serotonin transporter in limbic and motor compartments of the nucleus accumbens.

Authors:  V M Pickel; J Chan
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

5.  The pro-inflammatory cytokine TNF-α regulates the activity and expression of the serotonin transporter (SERT) in astrocytes.

Authors:  Sandra Malynn; Antonio Campos-Torres; Paul Moynagh; Jana Haase
Journal:  Neurochem Res       Date:  2013-01-22       Impact factor: 3.996

6.  Uptake and metabolism of serotonin by ependymal primary cultures.

Authors:  Stephan Verleysdonk; Bernd Hamprecht; Mirna Rapp; John Wellard
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 7.  Gliogenesis and glial pathology in depression.

Authors:  G Rajkowska; J J Miguel-Hidalgo
Journal:  CNS Neurol Disord Drug Targets       Date:  2007-06       Impact factor: 4.388

Review 8.  From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

Authors:  Gerard Sanacora; Mounira Banasr
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

9.  Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strains.

Authors:  Cristina S Benton; Brooke H Miller; Sean Skwerer; Oscar Suzuki; Laura E Schultz; Michael D Cameron; J S Marron; Mathew T Pletcher; Tim Wiltshire
Journal:  Psychopharmacology (Berl)       Date:  2011-11-24       Impact factor: 4.530

10.  Neuroprotective Role of Astroglia in Parkinson Disease by Reducing Oxidative Stress Through Dopamine-Induced Activation of Pentose-Phosphate Pathway.

Authors:  Kyoko Mashima; Shinichi Takahashi; Kazushi Minami; Yoshikane Izawa; Takato Abe; Naoki Tsukada; Takako Hishiki; Makoto Suematsu; Mayumi Kajimura; Norihiro Suzuki
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.